ViroStatics

From EverybodyWiki Bios & Wiki



ViroStatics srl develops drugs to overcome the underlying cellular perturbations common to cancer and viral diseases - dysregulation of cellular transcription and uncontrolled cell proliferation. To this end, ViroStatics has focused on selectively targeting the Cyclin Dependent Kinases (CDKs) involved in these perturbations (CDK9 and CDK4/6).

History[edit]

ViroStatics was formed In 2007 as a for-profit spin-off from the Research Institute for Human and Genetic Therapy (RIGHT), a US-based 501(c)3 corporation pursuing innovative antiviral therapies and vaccine research.

Led by CEO Franco Lori, MD, PhD, ViroStatics has its corporate headquarters in Sassari (Sardinia) Italy, R&D laboratories in the Science and Technology Park of Sardinia (Sardegna Ricerche) in Alghero (Sardinia) and Business Development offices in North America.

Drugs[edit]

ViroStatics has discovered and is developing novel, highly potent inhibitors, which selectively target CDK4/6/9 in a single molecule for a multifaceted approach for the durable treatment of cancers and viral diseases.

The Company has developed a robust pipeline of proprietary compounds, with patent protection beyond 2030, for a number of distinct disease indications.

Viral disease program: ViroStatics’ unique multifaceted compounds offer the potential for a paradigm shift in the treatment of viral diseases

  • HIV/AIDS: Preclinical Development – Clinical Candidate with Paradigm Shift Potential to Affect the HIV Reservoirs
  • Other Viruses: Lead Selection for a number of viruses including HPV, HBV and Herpes Viruses

Oncology program: Designed to Address the Unmet Medical Need for Durable Treatment for Cancers

  • Compounds identified with potential for multiple cancer indications

External links[edit]


This article "ViroStatics" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:ViroStatics. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.